These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2729754)

  • 21. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
    Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
    Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL
    J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization.
    Sato H; Silveira L; Fingerlin T; Dockstader K; Gillespie M; Lagan AL; Lympany P; Sawyer RT; du Bois RM; Welsh KI; Maier LA
    J Allergy Clin Immunol; 2007 Mar; 119(3):687-96. PubMed ID: 17208287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The beryllium bronchoalveolar lavage lymphocyte proliferation test: indicator of beryllium sensitization, inflammation or both?
    Heldt GH; Deubner DC
    Inhal Toxicol; 2015; 27(5):262-71. PubMed ID: 25942054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease.
    Fontenot AP; Kotzin BL; Comment CE; Newman LS
    Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic beryllium disease: a hypersensitivity disorder.
    Rossman MD
    Appl Occup Environ Hyg; 2001 May; 16(5):615-8. PubMed ID: 11370939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.
    Saltini C; Winestock K; Kirby M; Pinkston P; Crystal RG
    N Engl J Med; 1989 Apr; 320(17):1103-9. PubMed ID: 2469014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beryllium induces apoptosis in human lung macrophages.
    Kittle LA; Sawyer RT; Fadok VA; Maier LA; Newman LS
    Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):101-13. PubMed ID: 12102605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease.
    Mack DG; Lanham AK; Palmer BE; Maier LA; Watts TH; Fontenot AP
    J Immunol; 2008 Sep; 181(6):4381-8. PubMed ID: 18768897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease.
    Palmer BE; Mack DG; Martin AK; Maier LA; Fontenot AP
    J Allergy Clin Immunol; 2007 Jul; 120(1):184-91. PubMed ID: 17416406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A reconsideration of acute Beryllium disease.
    Cummings KJ; Stefaniak AB; Virji MA; Kreiss K
    Environ Health Perspect; 2009 Aug; 117(8):1250-6. PubMed ID: 19672405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent chronic beryllium disease in residents surrounding a beryllium facility.
    Maier LA; Martyny JW; Liang J; Rossman MD
    Am J Respir Crit Care Med; 2008 May; 177(9):1012-7. PubMed ID: 18244954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume.
    Cullen MR; Kominsky JR; Rossman MD; Cherniack MG; Rankin JA; Balmes JR; Kern JA; Daniele RP; Palmer L; Naegel GP
    Am Rev Respir Dis; 1987 Jan; 135(1):201-8. PubMed ID: 3492158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K; Wasserman S; Mroz MM; Newman LS
    J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
    Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
    Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical aspects and diagnosis of chronic berylliosis--a case report].
    Bargon J; Rust M; Kronenberger H; Buhl R; Meier-Sydow J
    Pneumologie; 1990 Feb; 44 Suppl 1():320-1. PubMed ID: 2367406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of inhaled corticosteroids on lung function in chronic beryllium disease.
    Mroz MM; Ferguson JH; Faino AV; Mayer A; Strand M; Maier LA
    Respir Med; 2018 May; 138S():S14-S19. PubMed ID: 29453139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive lung injury over a one-year period after a single inhalation exposure to beryllium sulfate.
    Sendelbach LE; Tryka AF; Witschi H
    Am Rev Respir Dis; 1989 Apr; 139(4):1003-9. PubMed ID: 2930060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.
    Day BJ; Huang J; Barkes BQ; Gillespie M; Li L; Maier LA
    Lung; 2018 Feb; 196(1):103-114. PubMed ID: 29080069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease.
    Rossman MD; Kern JA; Elias JA; Cullen MR; Epstein PE; Preuss OP; Markham TN; Daniele RP
    Ann Intern Med; 1988 May; 108(5):687-93. PubMed ID: 3282464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.